ALKERMES | ALKS - 流动资产

股票价格

37.48

每天变化

-0.88 -2.29%

每月一次

11.00%

每年

19.29%

Q2 预测

36.35

金融业

USD

USD 4.26B

现金及等价物

USD 351.55M

USD 73.25M

USD 1.36B

USD 599.5M

USD 1.58B

股息收益率

0

USD -48.28M

USD 80.26M

1.8K

EPS每股收益

USD -0.4

股本和储备

USD 1.75B

USD 331.33M

债务利息支出

USD 20.89M

USD 8.54M

USD 1.48B

USD 6.21B

USD -66.48M

USD 1.75B

USD -48.28M

普通股股本

USD 166.46M

39.33

USD -61.93M

USD 392.91M

销售和管理费用

USD 264.59M

USD 336.7M

贸易债权人

USD 102.36M

应收帐款人

USD 407.63M

	流动资产	更改		日
AbbVie	USD 33.53B		4.47B	2026-03
Acadia Pharmaceuticals	USD 1.1B		33.9M	2026-03
ALKERMES	USD 1.36B		570.52M	2026-03
Amgen	USD 31.48B		2.42B	2026-03
Biogen	USD 9.19B		216.3M	2026-03
BioMarin Pharmaceutical	USD 4.61B		651.58M	2026-03
Bristol-Myers Squibb	USD 27.21B		2.18B	2026-03
Coherus Biosciences	USD 206.71M		254.25M	2025-12
Eli Lilly	USD 54.84B		794M	2026-03
Gilead Sciences	USD 18.64B		1.25B	2026-03
Heron Therapeutics	USD 228.98M		9.08M	2026-03
Ionis Pharmaceuticals	USD 2.94B		52M	2026-03
J&J	USD 59.17B		3.55B	2026-03
Malin Corporation	EUR 62.6M		26.7M	2024-12
Merck	USD 35.02B		8.5B	2026-03
Minerva Neurosciences	USD 83.1M		70.08M	2025-12
Nektar Therapeutics	USD 266.27M		15.09M	2025-12
Neurocrine Biosciences	USD 2.44B		86.6M	2026-03
Otsuka Holdings	JPY 1.6T		21.76B	2026-03
Ovoca Bio	EUR 1.56M		3.39M	2025-06
Pfizer	USD 42.82B		76M	2026-03
Regeneron Pharmaceuticals	USD 18.21B		187.3M	2026-03
Vertex Pharmaceuticals	USD 11.73B		529.3M	2026-03